Skip to content
Institutional Investor early-stage Series A Series B Series D pre-IPO growth-stage PIPE LBO Est. 2003

NGN Capital

Venture capital firm investing in innovative healthcare and life sciences companies

📍 Heidelberg, Germany

About This Fund

Venture capital firm investing in innovative healthcare and life sciences companies. The firm focuses on providing financial resources and strategic support to companies with the potential to significantly impact the healthcare landscape. They actively seek opportunities in areas such as biotechnology, pharmaceuticals, medical devices, and diagnostics. The team brings extensive industry knowledge and operational expertise to help portfolio companies achieve their goals. They aim to foster growth and innovation within the healthcare sector, ultimately improving patient outcomes and driving advancements in medical technology. The firm's investment approach is centered on identifying promising ventures and partnering with talented entrepreneurs to build successful and sustainable businesses.

Investment Focus

Sectors
biotech biopharma medical devices diagnostics healthcare services
Stages
early-stage Series A Series B Series D pre-IPO growth-stage PIPE LBO
Check Size $7M-$40M
Geography
USA Europe

What They Look For

primarily US and Europe geography; late-stage emphasis with select early-stage; potential for above-average private equity returns

Preparing to pitch NGN Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →